The Effects of Two Different Breathing Techniques and Forward-Leaning Position on Physiological Parameters

NCT ID: NCT06928805

Last Updated: 2025-04-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

96 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-03

Study Completion Date

2025-02-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to determine the effects of balloon inflation and pursed-lip breathing exercises, in addition to the forward-leaning position, on physiological parameters in individuals with Chronic Obstructive Pulmonary Disease (COPD).

The hypotheses of the study are as follows:

H1\_1: The forward-leaning position and balloon inflation breathing exercise have a positive effect on physiological parameters in patients with Chronic Obstructive Pulmonary Disease (COPD).

H1\_2: The forward-leaning position and pursed-lip breathing exercise have a positive effect on physiological parameters in patients with COPD.

H1\_3: There is a significant difference in physiological parameters between the balloon inflation and pursed-lip breathing exercise groups and the control group.

Within this scope, the study will be conducted with three groups:

Intervention Group 1: Balloon inflation exercise applied in addition to the forward-leaning position.

Intervention Group 2: Pursed-lip breathing exercise applied in addition to the forward-leaning position.

Control Group: Standard practice implemented in the institution where the study is conducted.

Participants:

* A home exercise program will be designed for both intervention groups, allowing them to perform the exercises independently each day.
* The exercises will start with three sessions per day and will be increased by one session each week, continuing for a total of four weeks.
* Participants will visit the outpatient clinic in the 4th week for assessments and tests.
* Patients will be contacted weekly by the researcher via phone to ensure adherence to the program.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The exercise program will be determined in collaboration with a respiratory physiotherapist and implemented by the researcher. Accordingly, patients with stage II-III COPD (as determined by a physician) who visit the pulmonology outpatient clinic of the relevant hospital and meet the inclusion criteria will be given brief information about respiratory exercises, their benefits, and duration. They will then be instructed on how to perform the exercises through verbal commands for approximately 30 minutes. At the end of the session, the exercise guidelines will be practiced under the supervision of the researcher.

Before starting, the patient will be seated in a chair and allowed to rest for about 15 minutes. The patient will be informed about how to perform the walking test, the expected walking pace, and that they can stop and rest if they feel fatigued. Then, the patient will be asked to walk at a brisk pace for six minutes under the supervision of the researcher. During the walk, the researcher will continuously monitor the patient's oxygen saturation using a handheld pulse oximeter. If the patient exhibits signs of excessive sweating, pallor, or a significant drop in oxygen levels, the test will be terminated early.

Before and after the test, blood pressure, pulse rate, respiratory rate, oxygen saturation \[SpO2\], and dyspnea score using the Modified Borg Scale will be assessed, and the distance the patient walks in six minutes will be recorded. The six-minute walk test will be repeated at the end of the study. Subsequently, the patient will undergo a pulmonary function test, and the values for FVC, FEV1, FEV1/FVC ratio, and peak expiratory flow will be recorded.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease, COPD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pursed-lip breathing exercise

Group Type EXPERIMENTAL

Pursed-lip breathing exercise

Intervention Type OTHER

The pursed-lip breathing exercise was applied in addition to the forward-leaning position.

Balloon inflation exercise

Group Type EXPERIMENTAL

Balloon inflation exercise

Intervention Type OTHER

Balloon inflation exercise was applied in addition to the forward-leaning position.

Standard treatment

Group Type EXPERIMENTAL

Control (Standard treatment)

Intervention Type OTHER

Standard practice is implemented in the institution where the study is conducted.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Balloon inflation exercise

Balloon inflation exercise was applied in addition to the forward-leaning position.

Intervention Type OTHER

Pursed-lip breathing exercise

The pursed-lip breathing exercise was applied in addition to the forward-leaning position.

Intervention Type OTHER

Control (Standard treatment)

Standard practice is implemented in the institution where the study is conducted.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who have no communication and cooperation problems,
* Can speak and understand Turkish,
* Have a baseline saturation of \>90%,
* Have been diagnosed with Stage II and Stage III COPD,
* Have not had any infection or COPD exacerbation for at least 3 months,
* Have not participated in a pulmonary rehabilitation program in the last 3 months,
* Can walk without assistance,
* Do not have serious and/or unstable heart disease, neuromuscular disease, orthopedic disease or mental illness that may impair their physical activities of daily living,
* Willing to participate in the study will be included.

Exclusion Criteria

* Patients who have been hospitalized since the start of the study,
* Those receiving continuous oxygen therapy,
* Those who have cooperation problems,
* Those who cannot adapt to exercise,
* Those who have 2-3 or more acute attacks per year,
* Those with a history of pulmonary hypertension, malignancy, pulmonary thromboembolism, obstructive sleep apnea, unstable angina or myocardial infarction,
* Patients with a pulse rate over 120/minute will be excluded from the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Saglik Bilimleri Universitesi

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Semra Aciksoz, RN, Assistant Professor, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Health Sciences Turkey, Hamidiye Faculty ofNursing

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Health Sciences Turkey

Istanbul, Üsküdar, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SaglikBilimleriU Semra Aciksoz

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.